Exploring Polygenic Risk Scores and the Treatment of Complex Diseases

October 2, 2019

Find out what a polygenic risk score (PRS) is and how it can be used to predict disease risk and enable more effective treatment of complex diseases like immune disorders, cancer, heart disease, and psychiatric-neurological conditions. Genetics experts from University of Queensland and QIMR Berghofer Medical Research Institute discuss the utility of PRSs, how to create an effective PRS, and the future impact of polygenic risk scores. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel https://www.youtube.com/channel/UCxWMU29FF4kIG8YmQf6Zv0g?sub_confirmation=1 View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on